Hear from industry leaders on how to be successful in a new value-based care world.
Pharma and MedTech companies are struggling to understand the speed and impact of the value-based care transition in the U.S. healthcare system. While providers are working hard to comply with new changes driven by CMS and private payers, many companies wonder if the transition will be implemented as quickly as some stakeholders are claiming.
According to CMS sources, by 2020, 80% of the $3 trillion in U.S. healthcare spending will be tied to quality measures or value-based models. Are Pharma and MedTech companies ready for this rapid change? Will value-based care and pay for performance truly improve the U.S. healthcare system?
Send this to a friend